Emily Black

Education

• BSc(Pharm) (Dalhousie)
• ACPR (Dalhousie)
• PharmD (UBC)
  

Research Interests

Dr. Emily Black's primary research interests focus on infectious diseases including antimicrobial use and stewardship, immunizations, and pharmacy practice.  Current research projects include development and evaluation of antimicrobial stewardship initiatives, assessing and piloting of co-payment models for increased uptake of vaccines through community pharmacies, and exploring feasibility and acceptability of expanding community pharmacists’ scope for managing infectious diseases. For more information on Dr. Black’s research program please visit: smarterresearch.ca

Selected awards and honours

• Dalhousie University, Faculty of Health, Early Career Research Excellence Award (2022)
• UBC Faculty of Pharmaceutical Sciences Doctor of Pharmacy (Pharm.D.) Program Preceptor Award, July 2013

Selected publications

• CCA (Council of Canadian Academies). (2023). Overcoming Resistance. Ottawa (ON): Expert Panel on Antimicrobial Availability, CCA. Available at: cca-reports.ca
• content/uploads/2023/09/Overcoming-Resistance_digital_FINAL_2.pdf
• MacKinnon H, Slayter K, Comeau J, King C, Black E.  (2023) Evaluating the impact of incorporating clinical practice guidelines for management of infectious diseases into an electronic application (App). Infection Control and Hospital Epidemiology. 44:1417-22. Doi: 10.1017/ice.2022.286
• MacKinnon H, Slayter K, Comeau JL, Timberlake K, Science M, Black EK. (2023) Development of Quality Indicators to Evaluate the Appropriateness of Empiric Antimicrobial Use in Pediatric Patients.  Can J Hosp Pharm. 76(1):40-7.
• Humphrey M, MacDonald G, Neville H, Helwig M, Ramsey T, MacKinnon H, Sketris I, Johnston L, Black E. (2022) A Systematic Review of Antimicrobial Stewardship Interventions to Improve Management of Bacteriuria in Hospitalized Adults.  Annals of Pharmacotherapy. (Epub). https://doi.org/10.1177/10600280221134539
• Ring E, Isenor E, Slayter K, MacInnis M, Black E. (2022) Evaluating Barriers and Facilitators to Delivery of Hospital Pharmacy Services to Women, Children, and their Families During a Pandemic. Can J Hosp Pharm, 75(3):210-18.